Radiotherapy for painful bone metastases: A systematic review

Clinical Oncology

Volumn 9, Issue 3, 1997, Pages 150-154

  McQuay, H J ^a   Carroll, D ^a   Moore, R A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE METASTASIS; BONE PAIN; CANCER PAIN; CANCER RADIOTHERAPY; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030864720     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80070-2     Document Type: Review

References (24)

1. Hoskin P. Radiotherapy for bone pain 1995;63:137-9.
2. Jacox A, Carr DB, Payne R. Management of cancer pain. (Clinical practice guideline no. 9. Agency for Health Care Policy and Research UDo. AHCPR Publication no. 94-0592.) Rockville, MD: Public Health Service, 1994:41-74.
3. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996;17:1-12.
4. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-4.
5. Medical Research Council Lung Cancer Working Party. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Reserch Council by its Lung Cancer Working Party. Br J Cancer 1991;63:265-70.
6. Medical Research Council Lung Cancer Working Party. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992; 65:934-41.
7. Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg 1980;53:741-8.
8. Poulter CA, Cosmatos D, Rubin P, et al. A report of RTOG 8206. Int J Radiat Oncol Biol Phys 1992;23:207-14.
9. Hoskin PJ, Price P, Easton D, et al. A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 1992;23:74-8.
10. Cole DJ. A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol 1989;1:59-62.
11. Kagei K, Suzuki K, Shirato H, et al. A randomized trial of single and multifraction radiation therapy for bone metastasis: a preliminary report [Japanese]. Gan No Rinsho 1990; 36:2553-8.
12. Price P, Hoskin P, Easton D, et al. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 1986;6:247-55.
13. Hirokawa Y, Wadasaki K, Kashiwado K, et al. A multi institutional prospective randomized study of radiation therapy of bone metastases [Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 1988;48:1425-31.
14. Madsen E. Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy x 6 versus 10 Gy x 2. Int J Radiat Oncol Biol Phys 1983;9:1775-9.
15. Okawa T, Kita M, Goto M, et al. Randomized prospective clinical study of small, large and twice a day fraction radiotherapy for painful bone metastases. Radiother Oncol 1988;13:99-104.
16. Rasmusson B, Vejborg I, Jenson AB, et al. Irradiation of bone metastases in breast cancer patients: a randomized study with 1-year follow-up. Radiother Oncol 1995;34:179-84.
17. Blitzer PH. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 1985;55:1468-72.
18. Maxon H.R.3rd., Schorder LE, Hertzberg VS, et al. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. J Nucl Med 1991;32:1877-81.
19. Tong D, Gillick L, Hendrickson F. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 1982; 50:893-9.
20. Porter AT, McEwan AJ, Powe JE, et al. Results of a randomized Phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys 1993;25:805-13.
21. Quilty PM, Kirk D, Bolger JJ, et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 1994;31:33-40.
22. Lewington VJ, McEwan AJ, Ackery DM, et al. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 1991;27:954-8.
23. McQuay HJ, Jadad AR. Incident pain. In Hanks GW, editor. Palliative medicine: problem areas in pain and symptom management. (Cancer surveys vol. 21.) New York: Cold Spring Harbor, 1994:17-24.
24. Barton R, Hoskin PJ, Yarnold JR, et al. Radiotherapy for bone pain: is a single fraction good enough? Clin Radiol 1994;6:354-5.